Aquestive Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

AQST
Aquestive Therapeutics

Last Price:

4.89

Seasonality Move:

-18.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Aquestive Therapeutics Price Quote

$4.89

+0.01 (+1.66%)

(Updated: November 27, 2024 at 5:10 AM ET)

Aquestive Therapeutics Key Stats

Sell

Aquestive Therapeutics (AQST) is a Sell

Day range:

$4.75 - $5.06

52-week range:

$1.84 - $6.23

Dividend yield:

P/E ratio:

0.00

P/S ratio:

6.69

P/B ratio:

Volume:

1.5M

Avg. volume:

1.6M

1-year change:

130.19%

Market cap:

$444.9M

Revenue:

$50.6M

EPS:

$-0.46

How Much Does Aquestive Therapeutics Make?

How Much Are Aquestive Therapeutics's Sales Annually?
AQST Revenues are $50.6M
How Much Profit Does Aquestive Therapeutics's Make A Year?
AQST net income is -$7.9M

Is Aquestive Therapeutics Growing As A Company?

What Is Aquestive Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.04%
What Is Aquestive Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Aquestive Therapeutics Stock Price Performance

Did Aquestive Therapeutics Stock Go Up Last Month?
Aquestive Therapeutics share price went down by -11.11% last month
Did AQST's Share Price Rise Over The Last Year?
AQST share price rose by 130.19% over the past 1 year

What Is Aquestive Therapeutics 52-Week High & Low?

What Is Aquestive Therapeutics’s 52-Week High Share Price?
Aquestive Therapeutics has traded as high as $6.23 over the past 52 weeks
What Is Aquestive Therapeutics’s 52-Week Low Share Price?
Aquestive Therapeutics has traded as low as $1.84 over the past 52 weeks

Aquestive Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aquestive Therapeutics?

How Much Debt Does Aquestive Therapeutics Have?
Total long term debt quarterly is $31.3M
How Much Cash Does Aquestive Therapeutics Have?
Cash and short term investments quarterly total is $77.9M
What Is Aquestive Therapeutics’s Book Value Per Share?
Book value per share is -0.50

Is Aquestive Therapeutics Cash Flow Positive?

What Is AQST Cash Flow From Operations?
Cash flow from operations (TTM) is -$34.2M
What Is Aquestive Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $87.3M
What Is Aquestive Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$160K

Aquestive Therapeutics Return On Invested Capital